121 related articles for article (PubMed ID: 10864035)
1. Methotrexate concentration in cerebrospinal fluid of the space created by tumor removal.
Morikawa N; Mori T; Kawashima H; Takeyama M; Hori S
Biol Pharm Bull; 2000 Jun; 23(6):774-7. PubMed ID: 10864035
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of methotrexate in plasma and cerebrospinal fluid.
Morikawa N; Mori T; Abe T; Ghoda M; Takeyama M; Hori S
Ann Pharmacother; 1997 Oct; 31(10):1153-6. PubMed ID: 9337440
[TBL] [Abstract][Full Text] [Related]
3. Dose-related increases in cerebrospinal fluid concentrations of methotrexate in a postoperative patient with glioblastoma.
Morikawa N; Mori T; Kamenofuchi Y; Kawashima H; Takeyama M; Hori S
Ann Pharmacother; 1999 Sep; 33(9):952-6. PubMed ID: 10492499
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of cytosine arabinoside, methotrexate, nimustine and valproic acid in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy.
Morikawa N; Mori T; Abe T; Kawashima H; Takeyama M; Hori S
Biol Pharm Bull; 2000 Jun; 23(6):784-7. PubMed ID: 10864038
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of intra-arterially administered pirarubicin in plasma and cerebrospinal fluid of patients with glioma.
Morikawa N; Mori T; Takeyama M; Hori S
Biol Pharm Bull; 1998 Mar; 21(3):297-9. PubMed ID: 9556164
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of etoposide and carboplatin in cerebrospinal fluid and plasma during hyperosmotic disruption of the blood brain barrier and intraarterial combination chemotherapy.
Morikawa N; Mori T; Abe T; Kawashima H; Takeyama M; Hori S
Biol Pharm Bull; 1999 Apr; 22(4):428-31. PubMed ID: 10328568
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of nimustine, cytosine arabinoside, and methotrexate in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy.
Morikawa N; Mori T; Kawashima H; Takeyama M; Abe T; Kobayashi H
Biol Pharm Bull; 2001 Apr; 24(4):436-8. PubMed ID: 11305611
[TBL] [Abstract][Full Text] [Related]
8. [Effects of infusion duration of high-dose methotrexate on cerebrospinal fluid drug levels in lymphoma patients].
Lin XB; Zhou NN; Li S; Cai QQ; Xia ZJ; Liao H; Gao Y; Huang HQ
Ai Zheng; 2008 Oct; 27(10):1100-5. PubMed ID: 18851792
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia.
Csordas K; Hegyi M; Eipel OT; Muller J; Erdelyi DJ; Kovacs GT
Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of anticancer drugs in cerebrospinal fluid.
Morikawa N; Mori T; Kawashima H; Takeyama M; Hori S
Ann Pharmacother; 1998 Oct; 32(10):1008-12. PubMed ID: 9793590
[TBL] [Abstract][Full Text] [Related]
13. Effect of probenecid on ventricular cerebrospinal fluid methotrexate pharmacokinetics after intralumbar administration in nonhuman primates.
Salzer W; Widemann B; McCully C; Adamson PC; Balis FM
Cancer Chemother Pharmacol; 2001 Sep; 48(3):235-40. PubMed ID: 11592346
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid drug levels of leukemic children receiving intravenous 5 g/m2 methotrexate.
Millot F; Rubie H; Mazingue F; Mechinaud F; Thyss A
Leuk Lymphoma; 1994 Jun; 14(1-2):141-4. PubMed ID: 7920221
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis.
Tetef ML; Margolin KA; Doroshow JH; Akman S; Leong LA; Morgan RJ; Raschko JW; Slatkin N; Somlo G; Longmate JA; Carroll MI; Newman EM
Cancer Chemother Pharmacol; 2000; 46(1):19-26. PubMed ID: 10912573
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of nimustine, methotrexate, and cytosine arabinoside during cerebrospinal fluid perfusion chemotherapy in patients with disseminated brain tumors.
Morikawa N; Mori T; Kawashima H; Fujiki M; Abe T; Kaku T; Konisi Y; Takeyama M; Hori S
Eur J Clin Pharmacol; 1998 Jul; 54(5):415-20. PubMed ID: 9754986
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic drug monitoring of methotrexate in cerebrospinal fluid after systemic high-dose infusion in children: can the burden of intrathecal methotrexate be reduced?
Niemann A; Mühlisch J; Frühwald MC; Gerss J; Hempel G; Boos J
Ther Drug Monit; 2010 Aug; 32(4):467-75. PubMed ID: 20571463
[TBL] [Abstract][Full Text] [Related]
18. Safety and pharmacokinetic analysis of methotrexate administered directly into the fourth ventricle in a piglet model.
Sandberg DI; Solano J; Petito CK; Mian A; Mou C; Koru-Sengul T; Gonzalez-Brito M; Padgett KR; Luqman A; Buitrago JC; Alam F; Wilkerson JR; Crandall KM; Kuluz JW
J Neurooncol; 2010 Dec; 100(3):397-406. PubMed ID: 20440538
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid and plasma methotrexate levels following high-dose regimen given as a 3-hour intravenous infusion in children with nonHodgkin's lymphoma.
Vassal G; Valteau D; Bonnay M; Patte C; Aubier F; Lemerle J
Pediatr Hematol Oncol; 1990; 7(1):71-7. PubMed ID: 2397170
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion.
Evans WE; Hutson PR; Stewart CF; Cairnes DA; Bowman WP; Rivera G; Crom WR
Clin Pharmacol Ther; 1983 Mar; 33(3):301-7. PubMed ID: 6600662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
